United States · FDA National Drug Code directory
ETHOSUXIMIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0121-0670_14d8b71e-abd8-49d4-b4cc-82880e54db8c
- Product NDC
- 0121-0670
- Form
- SOLUTION
- Composition / generic term
- ETHOSUXIMIDE
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20001122
- Source listing expiry
- 20261231
Source-listed ingredients
- ETHOSUXIMIDE — 250 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 473 mL in 1 BOTTLE (0121-0670-16) · 0121-0670-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →